UnitedHealth Group Incorporated $UNH Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 374,797 shares of the healthcare conglomerate’s stock after purchasing an additional 2,881 shares during the period. UnitedHealth Group accounts for about 0.9% of Sumitomo Mitsui DS Asset Management Company Ltd’s portfolio, making the stock its 19th largest position. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in UnitedHealth Group were worth $137,580,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Bank of Stockton increased its holdings in shares of UnitedHealth Group by 12.9% in the third quarter. Bank of Stockton now owns 2,395 shares of the healthcare conglomerate’s stock valued at $879,000 after purchasing an additional 274 shares in the last quarter. CWA Asset Management Group LLC lifted its holdings in UnitedHealth Group by 5.3% during the 3rd quarter. CWA Asset Management Group LLC now owns 5,273 shares of the healthcare conglomerate’s stock worth $1,936,000 after buying an additional 267 shares in the last quarter. Secure Asset Management LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth $886,000. Maia Wealth LLC boosted its position in UnitedHealth Group by 17.7% in the 3rd quarter. Maia Wealth LLC now owns 14,252 shares of the healthcare conglomerate’s stock valued at $5,232,000 after buying an additional 2,148 shares during the last quarter. Finally, Tanager Wealth Management LLP acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $229,000. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on UNH shares. Jefferies Financial Group boosted their target price on UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Cantor Fitzgerald raised their price target on UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 17th. UBS Group reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. Mizuho boosted their price objective on UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a report on Monday, July 20th. Finally, JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a report on Friday. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $463.57.

Insider Buying and Selling

In related news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat and raised outlook: UnitedHealth reported adjusted earnings of $4.69 per share versus the $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Management raised its 2026 adjusted EPS outlook to at least $20.50, reinforcing investor confidence in operating execution and helping drive renewed interest in the shares. UnitedHealth Group Has The Market Asking A Bigger Question
• Positive Sentiment: Improving investor sentiment: Recent gains have followed the earnings beat and guidance increase, with analysts and investors reassessing medical-cost trends and the company’s ability to achieve its longer-term growth targets. Some coverage also points to potential efficiency gains from artificial intelligence and UnitedHealth’s diversified business model. Is UnitedHealth Group Stock a Buy After Another Solid Quarter?
• Neutral Sentiment: Healthcare-sector interest: UnitedHealth’s results are supporting interest in healthcare ETFs that include UNH, although diversified funds may reduce exposure to company-specific and Medicaid-related risks. A potentially divided government after the midterm elections could also be broadly favorable for healthcare stocks, but the policy outcome remains uncertain. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings
• Negative Sentiment: Valuation concerns: One analyst downgraded UnitedHealth from “strong buy” to “buy,” arguing that the stock appears fairly valued near 20 times forward earnings. The view suggests the recent rally may already reflect much of the earnings recovery, making additional gains more dependent on sustained execution. UnitedHealth Rating Downgrade
• Negative Sentiment: Coverage and enrollment pressure: A sharp decline in individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans in 2027 highlight regulatory, membership and pricing risks for health insurers. These developments could pressure growth and increase uncertainty around future medical costs and retention. Health Insurance Market Enrollment Decline

UnitedHealth Group Price Performance

Shares of UNH stock opened at $406.99 on Tuesday. The firm’s 50 day moving average price is $387.04 and its two-hundred day moving average price is $386.47. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The stock has a market cap of $365.31 billion, a PE ratio of 23.24, a PEG ratio of 1.45 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The company had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 20.64 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s payout ratio is 53.00%.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.